Tirzepatide versus Semaglutide for Weight Loss in Patients with Type 2 Diabetes Mellitus
Managing weight is a key aspect of treating type 2 diabetes mellitus (T2DM). Excess weight worsens insulin resistance and increases the risk of complications. Recently, two medications—tirzepatide and semaglutide—have gained attention for their potential to promote weight loss while improving blood sugar control. Both drugs belong to the class of incretin-based therapies, but they differ […]